Louise A Brinton1, Jake E Thistle2, Linda M Liao2, Britton Trabert2. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States. Electronic address: brinton@nih.gov. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States.
Abstract
OBJECTIVE: To clarify risk factors for rare vulvar neoplasms. METHODS: Within the NIH-AARP Study, among 201,469 women interviewed in 1995-1996 and followed for a mean of 13.8years, there were 370 diagnoses of incident vulvar neoplasms, including 170 invasive and 198 vulvar intraepithelial neoplasms grade 3 (VIN3). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated via multivariate logistic regression for various demographic, reproductive and lifestyle factors, with separate consideration of relations according to invasiveness, histology and age at diagnosis. RESULTS: Consistent with descriptive data, we found non-white women at lower risks of vulvar neoplasia than white women (HR=0.59, 95% CI 0.36-0.95). Significant risk factors for VIN3 included being divorced/separated (HR vs. currently married=1.77, 95% CI 1.24-2.51), a current cigarette smoker (3.88, 95% CI 2.64-5.72), a user of oral contraceptives (1.46, 95% CI 1.06-2.01), or a current user of menopausal hormones (1.73, 95% CI 1.24-2.41). Significant risk factors for invasive cancers were being obese (HR for BMI ≥30 vs. <25=1.62, 95% CI 1.10-2.40) or a current smoker (1.86, 95% CI 1.21-2.87). Cigarette smoking was a risk factor mainly for neoplasms shown in other investigations to be HPV-related, namely VIN3 and invasive squamous cell cancers (SCCs) occurring in the younger stratum of cases. In contrast, obesity was primarily associated with the development of invasive SCCs. CONCLUSIONS: Our results support that vulvar neoplasia is a heterogeneous disease. VIN3 demonstrated risk factors consistent with an HPV-related etiology, while invasive cancers were additionally affected by obesity, suggesting that further attention should focus on the role of chronic inflammatory conditions.
OBJECTIVE: To clarify risk factors for rare vulvar neoplasms. METHODS: Within the NIH-AARP Study, among 201,469 women interviewed in 1995-1996 and followed for a mean of 13.8years, there were 370 diagnoses of incident vulvar neoplasms, including 170 invasive and 198 vulvar intraepithelial neoplasms grade 3 (VIN3). Hazard ratios (HR) and 95% confidence intervals (CI) were calculated via multivariate logistic regression for various demographic, reproductive and lifestyle factors, with separate consideration of relations according to invasiveness, histology and age at diagnosis. RESULTS: Consistent with descriptive data, we found non-white women at lower risks of vulvar neoplasia than white women (HR=0.59, 95% CI 0.36-0.95). Significant risk factors for VIN3 included being divorced/separated (HR vs. currently married=1.77, 95% CI 1.24-2.51), a current cigarette smoker (3.88, 95% CI 2.64-5.72), a user of oral contraceptives (1.46, 95% CI 1.06-2.01), or a current user of menopausal hormones (1.73, 95% CI 1.24-2.41). Significant risk factors for invasive cancers were being obese (HR for BMI ≥30 vs. <25=1.62, 95% CI 1.10-2.40) or a current smoker (1.86, 95% CI 1.21-2.87). Cigarette smoking was a risk factor mainly for neoplasms shown in other investigations to be HPV-related, namely VIN3 and invasive squamous cell cancers (SCCs) occurring in the younger stratum of cases. In contrast, obesity was primarily associated with the development of invasive SCCs. CONCLUSIONS: Our results support that vulvar neoplasia is a heterogeneous disease. VIN3 demonstrated risk factors consistent with an HPV-related etiology, while invasive cancers were additionally affected by obesity, suggesting that further attention should focus on the role of chronic inflammatory conditions.
Authors: I A M van der Avoort; H Shirango; B M Hoevenaars; J M M Grefte; J A de Hullu; P C M de Wilde; J Bulten; W J G Melchers; L F A G Massuger Journal: Int J Gynecol Pathol Date: 2006-01 Impact factor: 2.762
Authors: Patricia L Judson; Elizabeth B Habermann; Nancy N Baxter; Sara B Durham; Beth A Virnig Journal: Obstet Gynecol Date: 2006-05 Impact factor: 7.661
Authors: G Nagel; H Concin; T Bjørge; K Rapp; J Manjer; G Hallmans; G Diem; C Häggström; A Engeland; M Almquist; H Jonsson; R Selmer; T Stocks; S Tretli; H Ulmer; P Stattin; A Lukanova Journal: Ann Oncol Date: 2010-10-21 Impact factor: 32.976
Authors: Mona Saraiya; Meg Watson; Xiaocheng Wu; Jessica B King; Vivien W Chen; Jennifer S Smith; Anna R Giuliano Journal: Cancer Date: 2008-11-15 Impact factor: 6.860
Authors: Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Mari Malkki; Hui-Wen Wilkerson; Federico M Farin; Joseph J Carter; Denise A Galloway; Janet R Daling; Effie W Petersdorf; Stephen M Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-07 Impact factor: 4.254
Authors: Ramakhosana S Hlapane; Thandekile L Khumalo; Bongumusa S Makhathini; Jagidesa Moodley Journal: South Afr J HIV Med Date: 2021-09-08 Impact factor: 2.744
Authors: Eike Burandt; Niclas C Blessin; Ann-Christin Rolschewski; Florian Lutz; Tim Mandelkow; Cheng Yang; Elena Bady; Viktor Reiswich; Ronald Simon; Guido Sauter; Sven Mahner; Nikolaus de Gregorio; Rüdiger Klapdor; Matthias Kalder; Elena I Braicu; Sophie Fürst; Maximilian Klar; Hans-Georg Strauß; Katharina Prieske; Linn Wölber Journal: Cancers (Basel) Date: 2022-08-31 Impact factor: 6.575